Imasogie has been a member of the Law School’s board since 2006. Imasogie received his law degrees from the University of Ife, Ile-Ife and the Nigerian Law School, and continued his education earning LLM degrees at both the London School of Economics and Political Science in 1984 and Penn’s Law School in 1985. A dedicated and engaged teacher, alumni supporter, and civic leader, he has more than 35 years of experience in law, finance and business management, healthcare, and the pharmaceutical industry.
“I am looking forward to working with Dean (Ted) Ruger and my colleagues on the board to continue the trajectory of growth and innovation that we have seen at the Law School,” said Imasogie. “As we emerge from the COVID-19 pandemic and strive for a more just and equitable society, the next few years will be critical as legal education continues to evolve to meet changing needs and demands.”
Imasogie is a serial entrepreneur and investor. He is the Senior Managing Partner and Co-Founder at PIPV Capital, a fully integrated Private Equity and Venture Capital Fund which specializes in Life Sciences, principally in the pharmaceutical sector.
Osagie has held senior commercial and R&D positions within pharmaceutical companies such as GSK, SmithKline, DuPont Merck and Endo, where he was the founding General Counsel and SVP for Corporate Development. Osagie has also been a Price Waterhouse Corporate Finance Partner as well as a practicing attorney with the Law Firm, Schnader, Harrison, Segal & Lewis.
Imasogie continues to be an adjunct professor at the Law School, where he teaches a seminar on “Intellectual Property and National Economic Value Creation” and has served as the I. Grant Irey Adjunct Professor.
Imasogie is also a member of the Board of Trustees of the University. He serves as Chairman and Founder of Zelira Therapeutics, Ilera Holdings and Ilera Holistic. Osagie was the Founder and Chairman of Ilera Healthcare, Ception Therapeutics Inc. and Trigenesis Therapeutics Inc. In addition, he serves on the board of a number of financial institutions such as FS-KKR Capital Corp. (NYSE: FSK), Haverford Trust and StoneRidge Investment. He is active in philanthropic, educational and artistic pursuits and serves on the executive committee of the Board of the Philadelphia Orchestra and the Philadelphia Museum of Art.
Chair of the Board of Advisors
“Perry’s leadership has been instrumental to the Law School’s success over the past decade and more,” said Ruger. “I look forward to continuing our partnership and working with him as an active member of the board. During his tenure as Chair, Perry has been instrumental in advancing the Law School into a new era of legal education. He remains steadfast in his dedication to the Law School and his guidance has been immeasurable.”
“I have valued the opportunity to work closely with Osagie as the Chair of the Board of Advisors and look forward to continuing to do so under his leadership,” noted Golkin. “The Law School is in a unique position to train future leaders who can solve complex problems, nationally and globally.”